Methods to enhance rnai oligonucleotide delivery to respiratory epithelial cells
AssigneeUniversity of Iowa Research Foundation
InventorsPaul B. McCray, JR., Beverly L. Davidson, Sateesh Krishnamurthy
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of reducing a level of a target mRNA in a well-differentiated airway epithelial cell by contacting the cell with a sensitizing agent followed by contacting the cell with a therapeutic RNAi agent.
Claims20
A method of reducing a level of a target mRNA in a well-differentiated airway epithelial cell comprising contacting the cell with a sensitizing agent followed by contacting the cell with a therapeutic RNAi agent, wherein the mRNA level of the target mRNA is reduced by at least 1% as compared to a control cell that has not been contacted with the sensitizing compound.
A method of treating a subject having an airway epithelial disease comprising administering to the subject an effective amount of a sensitizing agent and an effective amount of a therapeutic agent to alleviate the symptoms of the airway epithelial disease by inducing a therapeutic effect.
A kit for reducing a level of a target mRNA in a well-differentiated PAE cell comprising
- (a) a sensitizing agent,
- (b) a therapeutic RNAi molecule, and
- (c) instructions for contacting the cell with the sensitizing compound and the RNAi molecule to reduce the mRNA level of the target mRNA by at least 1% as compared to a control cell that has not been contacted with the sensitizing compound.
Dependencies are inferred from the claim text.